Origin articleStored source
U.S. missile stockpiles dwindle. And, FDA weighs approval of flu shots with mRNA tech
The U.S. Army's missile stockpile is dwindling and could take years to replenish. And, the Food and Drug Administration is deciding whether to approve a flu vaccine with mRNA technology.
Captured text
373 extracted characters
Source excerpt
Army's missile stockpile is dwindling and could take years to replenish.
And, the Food and Drug Administration is deciding whether to approve a flu vaccine with mRNA technology.
Army's missile stockpile is dwindling and could take years to replenish.
And, the Food and Drug Administration is deciding whether to approve a flu vaccine with mRNA technology.
Bold News stores the normalized extraction for evidence and analysis. This public wrapper shows a limited excerpt; use the original link for the publisher's complete presentation.